4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer

Stopped early · Phase 3

Conditions studied: Bladder Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known whether combination chemotherapy is more effective than observation alone in treating bladder cancer. PURPOSE: This randomized phase III trial is studying combination chemotherapy to see how well it works compared to observation alone in treating patients with bladder cancer.

Key facts

Study ID
NCT00005047
Run by
SWOG Cancer Research Network
People needed
521
Starts
1997-08-01
Expected to finish
2014-12-01
Last updated by the study team
2017-06-08

Who can join

Age: any, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.